About Complete Genomics
Complete Genomics is a Healthcare company based in San Jose (United States) founded in 2006 by Radoje Drmanac, and was acquired by Swiss Rockets in February 2026. It operates as a DNA sequencing platform for human genome analysis is developed. It operates in the Healthcare and Technology sectors. Complete Genomics has raised $124.99 million across 4 funding rounds from investors including Huada Gene, Orbimed and Swiss Rockets. Its website completegenomics.com draws about 11 thousand monthly visits. Complete Genomics offers products and services including DNBSEQâ„¢ Technology, Kits & Reagents, and Sequencing Platforms. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its legal entity is COMPLETE GENOMICS INC. Its competitors include Nanopore, Cepheid, PacBio, Omniome and QuantuMDx and 3 more; 8 of its 8 listed competitors have raised funding.
Company details
Complete Genomics was founded in 2006 in San Jose, United States, within the biotechnology sector focused on genomics. A proprietary DNA nanoball sequencing technology is utilized to create the Revolocity Platform, which supports whole genome and exome sequencing with fragment lengths of 250-500 bp. Analysis algorithms and data management software are provided for variant reports and assemblies, enabling research operations in human DNA sequencing.
- Headquarters San Jose, United States
- Founders Radoje Drmanac
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website completegenomics.com
- Social LinkedIn X YouTube
- Acquired by Huada Gene (Sep 2012)
- Legal Name Complete Genomics Inc.
- Total Equity Funding$124.99M (USD)
in 4 rounds
- Latest Funding Round$39M (USD), Series E
Aug 2010
- InvestorsHuada Gene
& 8 more
- Acquired by
Products & Services of Complete Genomics
Complete Genomics offers a comprehensive portfolio of products and services, including DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms.
Delivers accurate PCR-free NGS for genomics research applications.
Facilitates sample extraction and library preparation for sequencing.
Provides fast data for WGS and spatial omics analysis.
Apps and channels of Complete Genomics
its YouTube channel Complete Genomics has 111 subscribers and 30 videos.
Videos from Complete Genomics
The most watched videos on Complete Genomics's YouTube channel, Complete Genomics (111 subscribers). Click a video to play it here.
More on Complete Genomics.
Funding Insights of Complete Genomics
Complete Genomics has successfully raised a total of $124.99M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $39 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $124.99M
- Total Rounds 4
- Last Round Series E — $39M
- First Round $26.5M
(Mar 2008)
- Investors Count 7
All 4 funding rounds of Complete Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2010 | $39M | Series E | – | Sands Capital Management | |
| Aug 2009 | $45M | Series D | – | Orbimed, EW Healthcare Partners | |
| Jul 2009 | $14.49M | Series C | – | – | – |
| Mar 2008 | $26.5M | Series C | – | Enterprise Partners Venture Capital, Highland Capital Partners | – |
9 investors in total: 9 institutional.
Investors in Complete Genomics
Complete Genomics has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Huada Gene, Orbimed and Swiss Rockets.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in US life sciences and healthtech firms. | – | prospectventures.com | Palo Alto, United States | |
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Venture capital investment and entrepreneur support services. | – | hcp.com | - | |
- | – | epvc.com | - | |
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | – | ewhealthcare.com | New York, United States | |
Early-stage VC investments are focused primarily on US companies. | – | ovpevents.com | Seattle, United States | |
Manages diversified investment funds and portfolios for clients. | 1992 | sandscap.com | Arlington, United States | |
Genomics research and sequencing services are provided in China. | 1999 | genomics.cn | Shenzhen, China | |
Incubator and accelerator for biotech startups. This entity identifies, invests in, and cultivates promising biotech ventures. Services include mentorship, funding, access to resources, legal and regulatory guidance, and a network of industry experts. The focus is on accelerating growth and achieving goals for portfolio companies, providing financial resources and expertise in drug discovery, development, manufacturing, and regulatory affairs. Support extends to business and management topics, legal and IT support, market access, financing, and business development. The goal is to foster innovation and improve patient outcomes. | 2018 | swissrockets.com | Basel, Switzerland |
Investor details for Complete Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Complete Genomics
7 people are tracked at Complete Genomics (1 in leadership, 6 in board & advisors).
| Name | Role | Group |
|---|---|---|
Radoje Drmanac | Co-Founder & CSO | Leadership |
Mark Chee | Board Member | Board & advisors |
David P. Dimmock | Board Member | Board & advisors |
George Church | Board Member | Board & advisors |
Brynn Levy | Board Member | Board & advisors |
Leroy Hood | Board Member | Board & advisors |
Elaine Lyon | Board Member | Board & advisors |
Complete people profiles for Complete Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Complete Genomics
6 dated milestones of Complete Genomics across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Complete Genomics is founded.
- Funding First funding round of $26.5M.
- Funding Latest funding round, Series E, of $39.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Huada Gene.
- Exit Acquired by Swiss Rockets.
Competitors of Complete Genomics
Complete Genomics has 8 listed competitors in our database, 8 of them funded. They include Nanopore, Cepheid, PacBio, Omniome and QuantuMDx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanoporetech.com | 2005 | Oxford, United Kingdom | $1.34B | 705 | Nanopore-based electronic systems for single-molecule analysis are developed. | |
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| quantumdx.com | 2008 | Newcastle Upon Tyne, United Kingdom | $57.26M | 98 | Handheld diagnostic and sequencing devices are developed for personalized healthcare. | |
| bionano.com | 2002 | San Diego, United States | $124.2M | – | Provider of genome analysis solutions to researchers and clinicians | |
| genapsys.com | 2010 | Redwood, United States | $313.03M | 60 | Provider of DNA sequencing technologies for applied genomic testing and medical sequencing | |
| fluidigm.com | 1999 | San Francisco, United States | $40.53M | 205 | Instruments for life sciences research and applications are developed. |
Detailed competitors of Complete Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Complete Genomics
The website of Complete Genomics (completegenomics.com) receives about 11.4K visits a month.
- Monthly visits11.4K
▲ 28.1% vs previous month
Websites whose visitors overlap most with Complete Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| illumina.com | 100% | 672.7K | #61,793 | View details | |
biocurious.org | biocurious.org | 88% | – | #5,636,388 | – |
cgatools.sourceforge.net | cgatools.sourceforge.net | 87% | – | – | – |
1000genomes.org | 1000genomes.org | 84% | – | – | – |
 thegenomefactory.blogspot.com | thegenomefactory.blogspot.com | 83% | – | #9,664,172 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Complete Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Complete Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Complete Genomics
Complete news archive for Complete Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Complete Genomics
Complete Genomics was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Complete Genomics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Complete Genomics is a funded company, having raised a total of $124.99M across 4 funding rounds to date. The company's 1st funding round was a Series C of $26.5M, raised on Mar 2008.
Complete Genomics was founded in 2006 in San Jose, United States, within the biotechnology sector focused on genomics. A proprietary DNA nanoball sequencing technology is utilized to create the Revolocity Platform, which supports whole genome and exome sequencing with fragment lengths of 250-500 bp. Analysis algorithms and data management software are provided for variant reports and assemblies, enabling research operations in human DNA sequencing.
Complete Genomics offers DNBSEQâ„¢ Technology, Kits & Reagents, and Sequencing Platforms.
Complete Genomics has 9 investors. Key investors include Huada Gene, Orbimed, Swiss Rockets, Prospect Venture Partners, and Highland Capital Partners.
Complete Genomics operates through Complete Genomics Inc..
Yes. Complete Genomics was acquired by Huada Gene in September 2012.